Capital Advisors, Ltd. LLC Eli Lilly & CO Transaction History

Capital Advisors, Ltd. LLC

$806 Million
Q3 2024

A detailed history of Capital Advisors, Ltd. LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 1,432 shares of LLY stock, worth $1.07 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,432

Previous 1,404 1.99%

Holding current value

$1.07 Million

Previous $1.27 Million 0.16%

% of portfolio

0.16%

Previous 0.16%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $21,619 - $26,880	28 Added 1.99%	1,432 $1.27 Million
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $30,444 - $38,179	42 Added 3.08%	1,404 $1.27 Million
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $8,883 - $11,884	15 Added 1.11%	1,362 $1.06 Million
Q3 2023 Oct 27, 2023	BUY	$434.7 - $599.3 $19,561 - $26,968	45 Added 3.46%	1,347 $723,000
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $216,406 - $289,360	617 Added 90.07%	1,302 $611,000
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $151,587 - $178,032	-488 Reduced 41.6%	685 $235,000
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $172,993 - $201,572	538 Added 84.72%	1,173 $241,000
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $5,336 - $6,081	18 Added 2.92%	635 $205,000
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $3,344 - $3,927	12 Added 1.98%	617 $200,000
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $1,877 - $2,333	8 Added 1.34%	605 $173,000
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $12,141 - $15,068	54 Added 9.94%	597 $165,000
Q3 2019 Oct 23, 2019	SELL	$106.79 - $116.16 $43,249 - $47,044	-405 Reduced 42.72%	543 $61,000
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $411,363 - $480,165	-3,713 Reduced 79.66%	948 $105,000
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $359,223 - $398,701	4,661	4,661 $399,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.

Account

Capital Advisors, Ltd. LLC Eli Lilly & CO Transaction History